{"transactions":[{"id":2771411,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"officer_title":"Former Director and CEO"}}],"security":"Common Stock","published_at":"2021-03-27T01:54:22.000Z","date":"2021-03-24","kind":"tax_withholding","acquired":false,"shares":9944,"price":2.67,"value":26550.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred in connection with the closing of the merger (the \"Merger\") contemplated by the Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") by and among NTN Buzztime Inc., BIT Merger Sub, Inc. and Brooklyn Immunotherapeutics LLC.  The number of shares withheld was determinable on March 24, 2021.  No shares were sold in connection with this transaction. None of the share amounts in this Form 4 reflect the 2 for 1 reverse stock split implemented by the issuer on March 25, 2021 in connection with the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred in connection with the closing of the merger (the \"Merger\") contemplated by the Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") by and among NTN Buzztime Inc., BIT Merger Sub, Inc. and Brooklyn Immunotherapeutics LLC.  The number of shares withheld was determinable on March 24, 2021.  No shares were sold in connection with this transaction. None of the share amounts in this Form 4 reflect the 2 for 1 reverse stock split implemented by the issuer on March 25, 2021 in connection with the Merger."}],"balance_after":128520,"source":{"system":"sec-edgar","filing":"0001140361-21-010365","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000114036121010365/form4.xml","form_type":"4"}},{"id":2776994,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-03-22T23:00:19.000Z","date":"2021-03-19","kind":"tax_withholding","acquired":false,"shares":207,"price":3.53,"value":730.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on March 19, 2021. No shares were sold in connection with this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on March 19, 2021. No shares were sold in connection with this transaction."}],"balance_after":138464,"source":{"system":"sec-edgar","filing":"0001493152-21-006564","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315221006564/ownership.xml","form_type":"4"}},{"id":2844961,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-02-22T22:30:16.000Z","date":"2021-02-19","kind":"tax_withholding","acquired":false,"shares":207,"price":4.81,"value":995.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on February 19, 2021. No shares were sold in connection with this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on February 19, 2021. No shares were sold in connection with this transaction."}],"balance_after":138671,"source":{"system":"sec-edgar","filing":"0001493152-21-004521","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315221004521/ownership.xml","form_type":"4"}},{"id":2903650,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-01-20T22:30:09.000Z","date":"2021-01-19","kind":"tax_withholding","acquired":false,"shares":2987,"price":2.55,"value":7616.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on January 19, 2021. No shares were sold in connection with this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on January 19, 2021. No shares were sold in connection with this transaction."}],"balance_after":138878,"source":{"system":"sec-edgar","filing":"0001493152-21-001452","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315221001452/ownership.xml","form_type":"4"}},{"id":2936951,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-12-22T01:00:08.000Z","date":"2020-12-19","kind":"tax_withholding","acquired":false,"shares":170,"price":2.17,"value":368.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on December 19, 2020. No shares were sold in connection with this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on December 19, 2020. No shares were sold in connection with this transaction."}],"balance_after":141865,"source":{"system":"sec-edgar","filing":"0001493152-20-024073","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220024073/ownership.xml","form_type":"4"}},{"id":2972418,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-11-20T23:00:10.000Z","date":"2020-11-20","kind":"tax_withholding","acquired":false,"shares":170,"price":1.88,"value":319.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was\ndeterminable on November 20, 2020. No shares were sold in connection with this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was\ndeterminable on November 20, 2020. No shares were sold in connection with this transaction."}],"balance_after":142035,"source":{"system":"sec-edgar","filing":"0001493152-20-022151","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220022151/ownership.xml","form_type":"4"}},{"id":3002546,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-10-22T00:00:09.000Z","date":"2020-10-21","kind":"tax_withholding","acquired":false,"shares":2453,"price":2.05,"value":5028.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on October 21, 2020. No shares were sold in connection with this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on October 21, 2020. No shares were sold in connection with this transaction."}],"balance_after":142205,"source":{"system":"sec-edgar","filing":"0001493152-20-019769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220019769/ownership.xml","form_type":"4"}},{"id":3024257,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-09-23T23:00:09.000Z","date":"2020-09-22","kind":"tax_withholding","acquired":false,"shares":170,"price":1.99,"value":338.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on September 22, 2020. No shares were sold in connection with this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on September 22, 2020. No shares were sold in connection with this transaction."}],"balance_after":144658,"source":{"system":"sec-edgar","filing":"0001493152-20-018247","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220018247/ownership.xml","form_type":"4"}},{"id":3047198,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-08-26T23:05:15.000Z","date":"2020-08-25","kind":"tax_withholding","acquired":false,"shares":170,"price":2.62,"value":445.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on August 25, 2020. No shares were sold in connection with this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on August 25, 2020. No shares were sold in connection with this transaction."}],"balance_after":144828,"source":{"system":"sec-edgar","filing":"0001493152-20-016790","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220016790/ownership.xml","form_type":"4"}},{"id":3075371,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-07-28T22:00:14.000Z","date":"2020-07-28","kind":"tax_withholding","acquired":false,"shares":2453,"price":1.85,"value":4538.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on July 28, 2020. No shares were sold in connection with this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on July 28, 2020. No shares were sold in connection with this transaction."}],"balance_after":144998,"source":{"system":"sec-edgar","filing":"0001493152-20-014117","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220014117/ownership.xml","form_type":"4"}},{"id":3097232,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-06-30T20:30:35.000Z","date":"2020-06-29","kind":"tax_withholding","acquired":false,"shares":170,"price":3.15,"value":535.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on June 29, 2020. No shares were sold in connection with this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on June 29, 2020. No shares were sold in connection with this transaction."}],"balance_after":147451,"source":{"system":"sec-edgar","filing":"0001493152-20-012285","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220012285/ownership.xml","form_type":"4"}},{"id":3141843,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-05-20T23:10:58.000Z","date":"2020-05-20","kind":"tax_withholding","acquired":false,"shares":164,"price":1.55,"value":254.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on May 20, 2020. No shares were sold in connection with this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on May 20, 2020. No shares were sold in connection with this transaction."}],"balance_after":147621,"source":{"system":"sec-edgar","filing":"0001493152-20-009577","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220009577/ownership.xml","form_type":"4"}},{"id":3172107,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-04-22T12:00:25.000Z","date":"2020-04-21","kind":"tax_withholding","acquired":false,"shares":2363,"price":1.21,"value":2859.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on April 21, 2020. No shares were sold in connection with this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on April 21, 2020. No shares were sold in connection with this transaction."}],"balance_after":147785,"source":{"system":"sec-edgar","filing":"0001493152-20-006883","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220006883/ownership.xml","form_type":"4"}},{"id":3191807,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-03-31T23:32:08.000Z","date":"2020-03-27","kind":"grant","acquired":true,"shares":9506,"price":1.48,"value":14068.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares issued in lieu of a cash payout of the incentive compensation earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The price is the closing price of the issuer's common stock on the date of issuance. The number of shares issued is equal to the equivalent value of the cash payout earned net of amounts withheld by the issuer to satisfy tax withholding requirements divided by the closing price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares issued in lieu of a cash payout of the incentive compensation earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The price is the closing price of the issuer's common stock on the date of issuance. The number of shares issued is equal to the equivalent value of the cash payout earned net of amounts withheld by the issuer to satisfy tax withholding requirements divided by the closing price."}],"balance_after":150148,"source":{"system":"sec-edgar","filing":"0001493152-20-005524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220005524/ownership.xml","form_type":"4/A","original_submission_date":"2020-03-30"}},{"id":3191806,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-03-31T23:32:08.000Z","date":"2020-03-27","kind":"grant","acquired":true,"shares":1271,"price":1.48,"value":1881.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of salary earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The price is the closing price of the issuer's common stock on the date of issuance. The number of shares issued is equal to the equivalent value of the salary earned net of amounts withheld by the issuer to satisfy tax withholding requirements divided by the closing price."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of salary earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The price is the closing price of the issuer's common stock on the date of issuance. The number of shares issued is equal to the equivalent value of the salary earned net of amounts withheld by the issuer to satisfy tax withholding requirements divided by the closing price."}],"balance_after":140642,"source":{"system":"sec-edgar","filing":"0001493152-20-005524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220005524/ownership.xml","form_type":"4/A","original_submission_date":"2020-03-30"}},{"id":3192643,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-03-31T01:26:31.000Z","date":"2020-03-27","kind":"grant","acquired":true,"shares":10580,"price":1.48,"value":15658.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares issued in lieu of a cash payout of the incentive compensation earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The price is the closing price of the issuer's common stock on the date of issuance. The number of shares issued is equal to the equivalent value of the cash payout earned net of amounts withheld by the issuer to satisfy tax withholding requirements divided by the closing price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares issued in lieu of a cash payout of the incentive compensation earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The price is the closing price of the issuer's common stock on the date of issuance. The number of shares issued is equal to the equivalent value of the cash payout earned net of amounts withheld by the issuer to satisfy tax withholding requirements divided by the closing price."}],"balance_after":151222,"source":{"system":"sec-edgar","filing":"0001493152-20-005355","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220005355/ownership.xml","form_type":"4"}},{"id":3192642,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-03-31T01:26:31.000Z","date":"2020-03-27","kind":"grant","acquired":true,"shares":1074,"price":1.48,"value":1589.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of salary earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The price is the closing price of the issuer's common stock on the date of issuance. The number of shares issued is equal to the equivalent value of the salary earned net of amounts withheld by the issuer to satisfy tax withholding requirements divided by the closing price."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of salary earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The price is the closing price of the issuer's common stock on the date of issuance. The number of shares issued is equal to the equivalent value of the salary earned net of amounts withheld by the issuer to satisfy tax withholding requirements divided by the closing price."}],"balance_after":140642,"source":{"system":"sec-edgar","filing":"0001493152-20-005355","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220005355/ownership.xml","form_type":"4"}},{"id":3195714,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-03-26T01:12:00.000Z","date":"2020-03-25","kind":"tax_withholding","acquired":false,"shares":207,"price":1.48,"value":306.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on March 25, 2020. No shares were sold in connection with this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on March 25, 2020. No shares were sold in connection with this transaction."}],"balance_after":139371,"source":{"system":"sec-edgar","filing":"0001493152-20-004753","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220004753/ownership.xml","form_type":"4"}},{"id":3209973,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-03-16T21:30:25.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":947,"price":1.75,"value":1657.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of salary earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The price is the closing price of the issuer's common stock on the date of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of salary earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The price is the closing price of the issuer's common stock on the date of issuance."}],"balance_after":139578,"source":{"system":"sec-edgar","filing":"0001493152-20-004098","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220004098/ownership.xml","form_type":"4"}},{"id":3240010,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-03-02T22:00:11.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":778,"price":2.13,"value":1657.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of salary earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The price is the closing price of the issuer's common stock on the date of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of salary earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The price is the closing price of the issuer's common stock on the date of issuance."}],"balance_after":138631,"source":{"system":"sec-edgar","filing":"0001493152-20-003225","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220003225/ownership.xml","form_type":"4"}},{"id":3247797,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-02-26T13:00:41.000Z","date":"2020-02-25","kind":"tax_withholding","acquired":false,"shares":285,"price":2.05,"value":584.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on February 25, 2020. No shares were sold in connection with this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on February 25, 2020. No shares were sold in connection with this transaction."}],"balance_after":137853,"source":{"system":"sec-edgar","filing":"0001493152-20-002966","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220002966/ownership.xml","form_type":"4"}},{"id":3268914,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-02-18T22:00:12.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":877,"price":1.89,"value":1657.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of salary earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The price is the closing price of the issuer's common stock on the date of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of salary earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The price is the closing price of the issuer's common stock on the date of issuance."}],"balance_after":138138,"source":{"system":"sec-edgar","filing":"0001493152-20-002665","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220002665/ownership.xml","form_type":"4"}},{"id":3295841,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-02-04T01:00:12.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":743,"price":2.23,"value":1656.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of salary earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The price is the closing price of the issuer's common stock on the date of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares issued in lieu of salary earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The price is the closing price of the issuer's common stock on the date of issuance."}],"balance_after":137261,"source":{"system":"sec-edgar","filing":"0001493152-20-001536","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220001536/ownership.xml","form_type":"4"}},{"id":3297478,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-02-01T01:00:14.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":5102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares issued in lieu of a cash payout of the incentive compensation earned by the reporting person. Such shares were issued under the NTN Buzztime, Inc. 2019 Performance Incentive Plan."}],"balance_after":136518,"source":{"system":"sec-edgar","filing":"0001493152-20-001471","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220001471/ownership.xml","form_type":"4"}},{"id":3297477,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-02-01T01:00:14.000Z","date":"2020-01-29","kind":"tax_withholding","acquired":false,"shares":285,"price":2.43,"value":692.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on January 29, 2020. No shares were sold in connection with this transaction."}],"balance_after":131416,"source":{"system":"sec-edgar","filing":"0001493152-20-001471","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220001471/ownership.xml","form_type":"4"}},{"id":3297476,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-02-01T01:00:14.000Z","date":"2020-01-19","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares subject to a restricted stock unit award granted under the NTN Buzztime, Inc. 2019 Performance Incentive Plan. The award will vest as to 12.5% of the shares subject to the award on the three-month anniversary of the grant date and on each three month anniversary thereafter in substantially equal installments, in each case, subject to the reporting person's continued service to the issuer as of the applicable vesting date."}],"balance_after":131701,"source":{"system":"sec-edgar","filing":"0001493152-20-001471","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220001471/ownership.xml","form_type":"4"}},{"id":3334781,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2019-12-20T22:00:23.000Z","date":"2019-12-19","kind":"tax_withholding","acquired":false,"shares":242,"price":2.73,"value":660.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on December 19, 2019. No shares were sold in connection with this transaction."}],"balance_after":56701,"source":{"system":"sec-edgar","filing":"0001493152-19-019540","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219019540/ownership.xml","form_type":"4"}},{"id":3365156,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2019-11-21T01:00:11.000Z","date":"2019-11-20","kind":"tax_withholding","acquired":false,"shares":241,"price":2.62,"value":631.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on November 20, 2019. No shares were sold in connection with this transaction."}],"balance_after":56943,"source":{"system":"sec-edgar","filing":"0001493152-19-018145","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219018145/ownership.xml","form_type":"4"}},{"id":3389558,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2019-10-23T23:00:56.000Z","date":"2019-10-23","kind":"tax_withholding","acquired":false,"shares":241,"price":2.88,"value":694.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on October 23, 2019. No shares were sold in connection with this transaction."}],"balance_after":57184,"source":{"system":"sec-edgar","filing":"0001493152-19-015893","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219015893/ownership.xml","form_type":"4"}},{"id":3407501,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2019-09-24T23:43:06.000Z","date":"2019-09-24","kind":"tax_withholding","acquired":false,"shares":722,"price":2.28,"value":1646.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on September 24, 2019. No shares were sold in connection with this transaction."}],"balance_after":57425,"source":{"system":"sec-edgar","filing":"0001493152-19-014525","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219014525/ownership.xml","form_type":"4"}},{"id":3428811,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2019-08-27T21:35:29.000Z","date":"2019-08-27","kind":"tax_withholding","acquired":false,"shares":141,"price":2.77,"value":390.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on August 27, 2019. No shares were sold in connection with this transaction."}],"balance_after":58147,"source":{"system":"sec-edgar","filing":"0001493152-19-013436","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219013436/ownership.xml","form_type":"4"}},{"id":3453987,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2019-07-31T00:00:22.000Z","date":"2019-07-30","kind":"tax_withholding","acquired":false,"shares":141,"price":3.18,"value":448.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on July 30, 2019. No shares were sold in connection with this transaction."}],"balance_after":58288,"source":{"system":"sec-edgar","filing":"0001493152-19-011371","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219011371/ownership.xml","form_type":"4"}},{"id":3480783,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2019-06-24T21:00:14.000Z","date":"2019-06-21","kind":"tax_withholding","acquired":false,"shares":141,"price":3.47,"value":489.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on June 21, 2019. No shares were sold in connection with this transaction."}],"balance_after":58429,"source":{"system":"sec-edgar","filing":"0001493152-19-009632","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219009632/ownership.xml","form_type":"4"}},{"id":3517716,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2019-05-21T23:37:20.000Z","date":"2019-05-21","kind":"tax_withholding","acquired":false,"shares":171,"price":2.89,"value":494.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on May 21, 2019. No shares were sold in connection with this transaction."}],"balance_after":58570,"source":{"system":"sec-edgar","filing":"0001493152-19-008043","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219008043/ownership.xml","form_type":"4"}},{"id":3549577,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2019-04-25T20:45:40.000Z","date":"2019-04-23","kind":"tax_withholding","acquired":false,"shares":171,"price":3.8,"value":649.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on April 23, 2019. No shares were sold in connection with this transaction."}],"balance_after":58741,"source":{"system":"sec-edgar","filing":"0001493152-19-005944","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219005944/ownership.xml","form_type":"4"}},{"id":3577768,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2019-03-27T23:29:44.000Z","date":"2019-03-26","kind":"tax_withholding","acquired":false,"shares":171,"price":3.72,"value":636.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on March 26, 2019. No shares were sold in connection with this transaction."}],"balance_after":58912,"source":{"system":"sec-edgar","filing":"0001493152-19-004044","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219004044/ownership.xml","form_type":"4"}},{"id":3584116,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2019-03-21T20:45:22.000Z","date":"2019-03-19","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares subject to a restricted stock unit award granted under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan. The award will vest as to 16.67% of the shares subject to the award on the 6-month anniversary of the grant date and the remaining 83.33% of the shares will vest in 30 substantially equal monthly installments beginning on the 7-month anniversary of the grant date, in each case, subject to the reporting person's continued service to the issuer as of the applicable vesting date."}],"balance_after":59083,"source":{"system":"sec-edgar","filing":"0001493152-19-003715","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219003715/ownership.xml","form_type":"4"}},{"id":3634459,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2019-02-26T22:00:26.000Z","date":"2019-02-26","kind":"tax_withholding","acquired":false,"shares":171,"price":3.42,"value":584.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on February 26, 2019. No shares were sold in connection with this transaction."}],"balance_after":49083,"source":{"system":"sec-edgar","filing":"0001493152-19-002609","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219002609/ownership.xml","form_type":"4"}},{"id":3684588,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2019-01-30T01:00:14.000Z","date":"2019-01-29","kind":"tax_withholding","acquired":false,"shares":171,"price":3.18,"value":543.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on January 29, 2019. No shares were sold in connection with this transaction."}],"balance_after":49254,"source":{"system":"sec-edgar","filing":"0001493152-19-001144","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219001144/ownership.xml","form_type":"4"}},{"id":3724127,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2018-12-20T22:00:26.000Z","date":"2018-12-19","kind":"tax_withholding","acquired":false,"shares":145,"price":2,"value":290.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on December 19, 2018. No shares were sold in connection with this transaction."}],"balance_after":49425,"source":{"system":"sec-edgar","filing":"0001493152-18-017753","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315218017753/ownership.xml","form_type":"4"}},{"id":3758193,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2018-11-21T01:00:21.000Z","date":"2018-11-20","kind":"tax_withholding","acquired":false,"shares":144,"price":2.87,"value":413.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on November 20, 2018. No shares were sold in connection with this transaction."}],"balance_after":49570,"source":{"system":"sec-edgar","filing":"0001493152-18-016584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315218016584/ownership.xml","form_type":"4"}},{"id":3784559,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2018-10-24T12:30:35.000Z","date":"2018-10-23","kind":"tax_withholding","acquired":false,"shares":145,"price":4.32,"value":626.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on October 23, 2018. No shares were sold in connection with this transaction."}],"balance_after":49714,"source":{"system":"sec-edgar","filing":"0001493152-18-014819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315218014819/ownership.xml","form_type":"4"}},{"id":3808717,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2018-09-25T20:30:17.000Z","date":"2018-09-25","kind":"tax_withholding","acquired":false,"shares":857,"price":4.23,"value":3625.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on September 25, 2018. No shares were sold in connection with this transaction."}],"balance_after":49859,"source":{"system":"sec-edgar","filing":"0001493152-18-013716","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315218013716/ownership.xml","form_type":"4"}},{"id":3987065,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2018-03-21T21:01:42.000Z","date":"2018-03-19","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares subject to a restricted stock unit award granted under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan.  The award will vest as to 16.67% of the shares subject to the award on the 6-month anniversary of the grant date and the remaining 83.33% of the shares will vest in 30 substantially equal monthly installments beginning on the 7-month anniversary of the grant date, in each case, subject to the reporting person's continued service to the issuer as of the applicable vesting date."}],"balance_after":50716,"source":{"system":"sec-edgar","filing":"0001493152-18-003720","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315218003720/form4.xml","form_type":"4"}},{"id":4387862,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2017-03-15T01:47:38.000Z","date":"2017-03-13","kind":"grant","acquired":true,"shares":7506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of a cash payout of the incentive compensation earned by the reporting person under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan and pursuant to the NTN Buzztime, Inc. Executive Incentive Plan for Eligible Employees of NTN Buzztime, Inc. Fiscal Year 2016, as amended (the 2016 EIP). Under the 2016 EIP, the decision to pay the incentive compensation earned in shares instead of in cash is made by the Nominating and Corporate Governance/Compensation Committee of the Board of Directors of the issuer at its discretion and in its sole determination."}],"balance_after":35716,"source":{"system":"sec-edgar","filing":"0001493152-17-002428","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315217002428/form4.xml","form_type":"4"}},{"id":4554156,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2016-11-17T01:48:50.000Z","date":"2016-11-15","kind":"grant","acquired":true,"shares":250,"price":7.47,"value":1867.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As custodian of Minor Child 2."}],"balance_after":2100,"source":{"system":"sec-edgar","filing":"0001493152-16-015200","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315216015200/form4.xml","form_type":"4"}},{"id":4554155,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2016-11-17T01:48:50.000Z","date":"2016-11-15","kind":"grant","acquired":true,"shares":250,"price":7.47,"value":1867.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"As custodian of Minor Child 1."}],"balance_after":2100,"source":{"system":"sec-edgar","filing":"0001493152-16-015200","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315216015200/form4.xml","form_type":"4"}},{"id":4554154,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2016-11-17T01:48:50.000Z","date":"2016-11-15","kind":"grant","acquired":true,"shares":500,"price":7.46,"value":3730.0,"ownership":{"direct":true},"balance_after":28210,"source":{"system":"sec-edgar","filing":"0001493152-16-015200","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315216015200/form4.xml","form_type":"4"}},{"id":4566215,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2016-11-08T00:30:20.000Z","date":"2016-11-04","kind":"grant","acquired":true,"shares":1750,"price":6.64,"value":11620.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As custodian of Minor Child 2."}],"balance_after":31410,"source":{"system":"sec-edgar","filing":"0001493152-16-014599","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315216014599/form4.xml","form_type":"4"}},{"id":4566214,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2016-11-08T00:30:20.000Z","date":"2016-11-04","kind":"grant","acquired":true,"shares":1750,"price":6.64,"value":11620.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"As custodian of Minor Child 1."}],"balance_after":29660,"source":{"system":"sec-edgar","filing":"0001493152-16-014599","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315216014599/form4.xml","form_type":"4"}},{"id":4566213,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":140880,"kind":"person","name":"Wolff Allen","position":1,"cik":"0001628529","reported_name":"Wolff Allen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and EVP"}}],"security":"Common Stock","published_at":"2016-11-08T00:30:20.000Z","date":"2016-11-04","kind":"grant","acquired":true,"shares":26000,"price":6.64,"value":172640.0,"ownership":{"direct":true},"balance_after":27910,"source":{"system":"sec-edgar","filing":"0001493152-16-014599","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315216014599/form4.xml","form_type":"4"}}]}